4DMedical Limited FDMDF
Set alert
1.95 USD -0.45 -18.75%
At close · Oct 30
2.40 Day range 2.40
0.8701 52-week range 5.00
- YTD
- -17.02%
- 1 year
- +56.00%
- Open
- 2.40
- Prev close
- 2.40
- Mkt cap
- 1.17B
- Vol
- 100
- Avg vol
- 669
- EPS
- -0.26
- P/E
- 0.00
More statistics
- Low
- 2.40
- High
- 2.40
- Earnings
- Aug 27, 2026
3M chart
Events in this range
- Aug 27, 2026Earnings: —; estimate -0.02799; surprise —%
Signals (20)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| RSI: Overbought | Aug 5, 2026 | 2 months ago |
Financial health
Altman Z-Score
4.09 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -11.1×
FY 2017 5y median -7.9× FY 2026
P/S 367×
FY 2017 5y median 324× FY 2026
P/B 15.2×
FY 2017 5y median 3.3× FY 2026
P/FCF -80.5×
FY 2017 5y median -9.8× FY 2026
EV/EBITDA -44.6×
FY 2017 5y median -5.5× FY 2026
EV/Sales 328×
FY 2017 5y median 241× FY 2026
FCF Yield -1.2%
FY 2017 5y median -10.2% FY 2026
Profitability
Gross Margin -539.2%
FY 2017 5y median 26.6% FY 2026
Operating Margin -813.7%
FY 2017 5y median -1528.4% FY 2026
Net Margin -2895.1%
FY 2017 5y median -2332.6% FY 2026
ROE -120.1%
FY 2017 5y median -46.8% FY 2026
ROIC -15.7%
FY 2017 5y median -38.1% FY 2026
ROA -56.0%
FY 2017 5y median -33.1% FY 2026
Growth (YoY)
Revenue 20.5%
FY 2017 FY 2026
Operating Income -96.4%
FY 2017 FY 2026
EPS (diluted) 78.6%
FY 2017 FY 2026
Free Cash Flow 6.9%
FY 2017 FY 2026
Financial Health
Current Ratio 30.8×
FY 2017 5y median 4.6× FY 2026
Quick Ratio 30.8×
FY 2017 5y median 4.6× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 5.3×
FY 2017 5y median 1.3× FY 2026
Interest Coverage -21.1×
FY 2017 5y median -124× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30